GNLX

Several events have impacted Genelux Corp.'s stock price in the past six months. The company participated in healthcare conferences. A proposed public offering of common stock led to significant stock price decreases in early January 2026. The stock price increased following the announcement of a virtual fireside chat and upcoming conference participation. Reporting of Fourth Quarter and Full Year 2025 financial results and business updates coincided with a stock price decrease. Shareholder dilution was identified as a new major risk, and the average analyst price target decreased. First Quarter 2026 financial results, including a net loss and increased R&D expense, coincided with a negative next-day stock move. The stock price increased on May 8, 2026. There have been insider selling transactions with no insider buying activity reported over the past three months.